Artificial neural networks in evaluation and optimization of modified release solid dosage forms

Pharmaceutics

Volumn 4, Issue 4, 2012, Pages 531-550

  Ibrić, Svetlana ^a   Djuriš, Jelena ^a   Parojčić, Jelena ^a   Djurić, Zorica ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Artificial neural networks; Modified release; Pharmaceutical development

Indexed keywords

THEOPHYLLINE;

ARTIFICIAL NEURAL NETWORK; CONTROLLED RELEASE FORMULATION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG RELEASE; DRUG STABILITY; HUMAN; INTERMETHOD COMPARISON; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MONTE CARLO METHOD; PARTICLE SIZE; PHYSICAL CHEMISTRY; POROSITY; PREDICTION; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; REVIEW; TABLET HARDNESS; TENSILE STRENGTH;

EID: 84871581498     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics4040531     Document Type: Review

References (44)

1. Snee, R.D. Quality by design-four years and three myths later. Pharm. Proc. 2009, 2, 14-16.
2. Lewis, G.A.; Mathieu, D.; Luu, P.T. Pharmaceutical Experimental Design; Marcel Dekker: New York, NY, USA, 1999.
3. Bishop, C.M. Pattern Recognition and Machine Learning; Springer: Berlin, Germany, 2006.
4. Agatonovic-Kustrin, S.; Beresford, R. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J. Pharm. Biomed. Anal. 2000, 22, 717-727.
5. Sun, Y.; Peng, Y.; Chen, Y.; Shukla, A. Application of artificial neural networks in the design of controlled release drug delivery systems. Adv. Drug Deliv. Rev. 2003, 55, 1201-1215.
6. Basheer, I.A.; Hajmeer, M. Artificial neural networks: Fundamentals, computing, design and application. J. Microbiol. Methods 2000, 43, 3-31.
7. Rosenblatt, F. Principles of Neurodynamics: Perceptrons and the Theory of Brain Mechanisms; Spartan Books: Washington DC, USA, 1961.
8. Rumelhart, D.E.; Geoffrey, E.H.; Williams, R.J. Parallel Distributed Processing: Explorations in the Microstructure of Cognition, Volume 1: Foundations; MIT Press: Massachusetts, UK, 1986.
9. Zhang, J.; Man, K.F. Time series prediction using recurrent neural network in multi-dimension embedding phase space. IEEE Syst. Man Cybern. Soc. 1998, 2, 11-14.
10. Specht, D.F. A general regression neural network. IEEE Trans. Neural Netw. 1991, 2, 568-576.
11. Patterson, D. Artificial Neural Networks; Prentice Hall: Singapore, 1996.
12. Ibrić, S.; Jovanović, M.; Djurić, Z.; Parojčić, J.; Solomun, L. The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance. J. Control. Release 2002, 82, 213-222.
13. Petrović, J.; Ibrić, S.; Betz, G.; Parojčić, J.; Durić, Z. Application of dynamic neural networks in the modeling of drug release from polyethylene oxide matrix tablets. Eur. J. Pharm. Sci. 2009, 38, 172-180.
14. Waibel, A.; Hanazawa, T.; Hinton, G.; Shikano, K.; Land, K. Phoneme recognition using time-delay neural networks. IEEE Trans. ASSP 1989, 37, 328-339.
15. Samarasinghe, S. Neural Networks for Applied Sciences and Engineering; Auerbach Publications: New York, NY, USA, 2006.
16. Köker, R. Design and performance of an intelligent predictive controller for a six-degree-of-freedom robot using the Elman network. Inf. Sci. 2006, 12, 1781-1799.
17. Elman, J.L. Finding structure in time. Cogn. Sci. 1990, 2, 179-211.
18. Goh, W.Y.; Lim, C.P.; Peh, K.K.; Subari, K. Application of a recurrent neural network to prediction of drug dissolution profiles. Neural Comput. Appl. 2002, 10, 311-317.
19. Hussain, A.S.; Yu, X.; Johnson, R.D. Application of neural computing in pharmaceutical product development. Pharm. Res. 1991, 8, 1248-1252.
20. Hussain, A.S.; Shivanand, P.; Johnson, R.D. Application of neural computing in pharmaceutical product development: Computer aided formulation design. Drug Dev. Ind. Pharm. 1994, 20, 1739-1752.
21. Chen, Y.; McCall, T.W.; Baichwal, A.R.; Meyer, M.C. The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. J. Control. Release 1999, 59, 33-41.
22. Turkoglu, M.; Aydin, I.; Murray, M.; Sakr, A. Modeling of a roller-compaction process using neural networks and genetic algorithms. Eur. J. Pharm. Biopharm. 1999, 48, 239-245.
23. Takayama, K.; Morva, A.; Fujikawa, M.; Hattori, Y.; Obata, Y.; Nagai, T. Formula optimization of theophylline controlled-release tablet based on artificial neural networks. J. Control. Release 2000, 68, 175-186.
24. Peh, K.K.; Lim, C.P.; Quek, S.S.; Khoh, K.H. Use of artificial neural networks to predict drug dissolution profiles and evaluation of network performance using similarity factor. Pharm. Res. 2000, 17, 1384-1389.
25. Vaithiyalingam, S.; Khan, M.A. Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion. Int. J. Pharm. 2002, 234, 179-193.
26. Ivić, B.; Ibrić, S.; Cvetković, N.; Petrović, A.; Trajković, S.; Djurić, Z. Application of design of experiments and multilayer perceptrons neural network in the optimization of diclofenac sodium extended release tablets with Carbopol® 71G. Chem. Pharm. Bull. 2010, 58, 947-949.
27. Ibrić, S.; Jovanović, M.; Djurić, Z.; Parojčić, J.; Petrović, S.D.; Solomun, L.J.; Stupar, B. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance. AAPS Pharm. Sci. Tech. 2003, 4, 62-70.
28. Ibrić, S.; Jovanović, M.; Djurić, Z.; Parojčić, J.; Solomun, L.; Lučić, B. Generalized regression neural networks in prediction of drug stability. J. Pharm. Pharmacol. 2007, 59, 745-750.
29. Petrović, J.; Ibrić, S.; Betz, G.; Djurić, Z. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees. Int. J. Pharm. 2012, 428, 57-67.
30. Djurǐ, J. Characterization of controlled release hydrophilic and lipid matrix tablets using in silico methods, Ph.D. dissertation, Belgrade University, Belgrade, Serbia, June 2010.
31. Zupancic Bozic, D.; Vrecer, F.; Kozjek, F. Optimization of diclofenac sodium dissolution from sustained release formulations using an artificial neural network. Eur. J. Pharm. Sci. 1997, 5, 163-169.
32. Reis, M.A.A.; Sinisterra, R.D.; Belchior, J.C. An alternative approach based on artificial neural networks to study controlled drug release. J. Pharm. Sci. 2004, 93, 418-430.
33. Chansanroj, K.; Petrović, J.; Ibrić, S.; Betz, G. Drug release control and system understanding of sucrose esters matrix tablets by artificial neural networks. Eur. J. Pharm. Sci. 2011, 44, 321-331.
34. Dowell, J.A.; Hussain, A.; Devane, J.; Young, D. Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulations: Initial trials and experience. J. Pharm. Sci. 1999, 88, 154-160.
35. Parojčić, J.; Ibrić, S.; Durić, Z.; Jovanović, M.; Corrigan, O.I. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation. Eur. J. Pharm. Sci. 2007, 30, 264-272.
36. De Matas, M.; Shao, Q.; Richardson, C.H.; Chrystyn, H. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks. Eur. J. Pharm. Sci. 2008, 33, 80-90.
37. Li, Y.; Rauth, A.M.; Wu, X.Y. Prediction of kinetics of doxorubicin release from sulfopropyl dextran ion-exchange microspheres using artificial neural networks. Eur. J. Pharm. Sci. 2005, 24, 401-410.
38. Lim, C.P.; Quek, S.S.; Peh, K.K. Prediction of drug release profiles using an intelligent learning system: An experimental study in transdermal iontophoresis. J. Pharm. Biomed. Anal. 2003, 31, 159-168.
39. Ivic, B.; Ibric, S.; Betz, G.; Djuric, Z. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN). Arch. Pharm. Res. 2010, 33, 103-113.
40. Chen, Y.; Jiao, T.; McCall, T.W.; Baichwal, A.R.; Meyer, M.C. Comparison of four artificial neural network software programs used to predict the in vitro dissolution of controlled-release tablets. Pharm. Dev. Tech. 2002, 7, 373-379.
41. Tan, C.; Degim, I.T. Development of sustained release formulation of an antithrombotic drug and application of fuzzy logic. Pharm. Dev. Tech. 2012, 17, 242-250.
42. Barmpalexis, P.; Kachrimanis, K.; Tsakonas, A.; Georgarakis, E. Symbolic regression via genetic programming in the optimization of a controlled release pharmaceutical formulation. Chemom. Intell. Lab. Syst. 2011, 107, 75-82.
43. Barmpalexis, P.; Kachrimanis, K.; Georgarakis, E. Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming. Eur. J. Pharm. Biopharm. 2011, 77, 122-131.
44. Colbourn, E.A.; Roskilly, S.J.; Rowe, R.C.; York, P. Modelling formulations using gene expression programming-A comparative analysis with artificial neural etworks. Eur. J. Pharm. Sci. 2011, 44, 366-374.